EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies

Yi Chen, Jiangqing Huang, Luyan Dong, Binbin Xu, Lei Li, Zhichang Zhao, Bin Li

Frontiers in Cellular and Infection Microbiology · 26.09.2024 · 14

DOI: 10.3389/fcimb.2024.1471477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 26.09.2024. Verfasst von Yi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Enterobacteriaceae Infections, Carbapenem-Resistant Enterobacteriaceae, Bacteremia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) pose a significant risk to patients with hematologic malignancies, yet the distinct features and outcomes of these infections are not thoroughly understood.

Methods

This retrospective study examined the characteristics and clinical outcomes of patients with Enterobacterales BSIs at the Hematology Department of Fujian Medical University Union Hospital from 2018 to 2022. Whole-genome sequencing was conducted on 45 consecutive CRE BSI isolates during this period.

Results

A total of 301 patients with Enterobacterales BSIs were included, with 65 (21.6%) cases of CRE and 236 (78.4%) cases of carbapenem-susceptible Enterobacterales (CSE). CRE infections accounted for 16.9% to 26.9% of all Enterobacterales BSIs, and carbapenem-resistant Klebsiella pneumoniae (CRKP) was the predominant strain. The most frequent sequence type (ST) and carbapenemase among CRKP were ST11 (68.6%) and bla KPC-2 (80.0%), respectively. Perianal infections, multiple infection foci, and a history of multiple hospitalizations, ICU stays, and prior CRE infections were identified as risk factors for CRE BSIs. Patients in the CRE group experienced significantly higher proportions of infection-related septic shock (43.1% vs. 19.9%, P < 0.0003) and 30-day all-cause mortality (56.9% vs. 24.6%, P < 0.0001) compared to those in the CSE group. Patient’s age and disease subtypes, strain subtypes, and antimicrobial treatment regimens significantly influenced survival in patients with CRE BSIs.

Conclusions

CRE BSIs are a frequent complication in patients with hematological malignancies undergoing treatment and are associated with poor survival rates. A comprehensive understanding of risk factors and ongoing surveillance of prevalent strains are essential for the effective management of these infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsEnterobacteriaceae InfectionsCarbapenem-Resistant EnterobacteriaceaeBacteremiaAnti-Bacterial AgentsWhole Genome SequencingHumansMaleFemaleMiddle AgedRetrospective StudiesAgedCarbapenemsRisk FactorsAdultKlebsiella pneumoniaebeta-LactamasesMicrobial Sensitivity TestsBacterial ProteinsGenome, Bacterial

Stichwörter der Autor:innen

carbapenem-resistant Enterobacteralesclinical characteristicshematological malignanciesprognosiswhole-genome sequencing

Substanzen

Anti-Bacterial AgentsCarbapenemsbeta-LactamasesBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China.
  • Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Clinical Laboratory, Fujian Medical University Union Hospital Pingtan Branch, Fuzhou, China.
  • Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China.

Zitieren

APA

Chen, Y., Huang, J., Dong, L., Xu, B., Li, L., Zhao, Z., & Li, B. (2024). Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1471477

Vancouver

Chen Y, Huang J, Dong L, Xu B, Li L, Zhao Z, et al. Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1471477

BibTeX
@article{Chen2024,
  author = {Chen, Yi and Huang, Jiangqing and Dong, Luyan and Xu, Binbin and Li, Lei and Zhao, Zhichang and Li, Bin},
  title = {Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1471477}
}
Kostenlos starten →